These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2299641)

  • 21. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
    Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):135-8. PubMed ID: 2552330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1987 Aug; 39(8):664-6. PubMed ID: 2888864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.
    Herrick-Davis K; Titeler M; Leonhardt S; Struble R; Price D
    J Neurochem; 1988 Dec; 51(6):1906-12. PubMed ID: 3141589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I; Combs MR; Jones DJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional correlates of serotonin 5-HT1 recognition sites.
    Hoyer D
    J Recept Res; 1988; 8(1-4):59-81. PubMed ID: 3290473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-694,247: a potent 5-HT1D receptor agonist.
    Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
    Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.
    Barone P; Jordan D; Atger F; Kopp N; Fillion G
    Brain Res; 1994 Feb; 638(1-2):85-94. PubMed ID: 8199879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [5-Hydroxytryptamine receptors].
    Segawa T
    Nihon Yakurigaku Zasshi; 1989 Aug; 94(2):91-102. PubMed ID: 2553557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated 5-hydroxytryptamine receptor-mediated responses in aortae from streptozotocin-induced diabetic rats.
    James GM; Hodgson WC; Davis EA; Haynes JM
    Br J Pharmacol; 1994 Jan; 111(1):370-6. PubMed ID: 8012721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible antidepressant dihydroergosine preferentially binds to 5-HT1B receptor sites in the rat hippocampus.
    Muck-Seler D; Pericić D
    J Neural Transm Gen Sect; 1993; 92(1):1-9. PubMed ID: 8329168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.